The bioactive peptides of CgA have shown promise as prognostic and diagnostic biomarkers for neuroendocrine tumors, cardiac disease, burn trauma and stress in humans [12, 35, 80–82]. This evidence concerns the gene CGA and neuroendocrine neoplasm.